Ubonvan Termsarasab

564 total citations
10 papers, 504 citations indexed

About

Ubonvan Termsarasab is a scholar working on Biomaterials, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Ubonvan Termsarasab has authored 10 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Biomaterials, 6 papers in Biomedical Engineering and 4 papers in Molecular Biology. Recurrent topics in Ubonvan Termsarasab's work include Nanoparticle-Based Drug Delivery (9 papers), Nanoplatforms for cancer theranostics (6 papers) and Advanced Drug Delivery Systems (4 papers). Ubonvan Termsarasab is often cited by papers focused on Nanoparticle-Based Drug Delivery (9 papers), Nanoplatforms for cancer theranostics (6 papers) and Advanced Drug Delivery Systems (4 papers). Ubonvan Termsarasab collaborates with scholars based in South Korea, Puerto Rico and Ethiopia. Ubonvan Termsarasab's co-authors include Hyun‐Jong Cho, Dae‐Duk Kim, Hyun Tae Moon, Jae‐Young Lee, In‐Soo Yoon, Seung-Hak Ko, Jae-Seong Shim, Ju-Hwan Park, Suk‐Jae Chung and Chang‐Koo Shim and has published in prestigious journals such as Journal of Controlled Release, Acta Biomaterialia and International Journal of Pharmaceutics.

In The Last Decade

Ubonvan Termsarasab

10 papers receiving 497 citations

Peers

Ubonvan Termsarasab
Jae-Seong Shim South Korea
Ubonvan Termsarasab
Citations per year, relative to Ubonvan Termsarasab Ubonvan Termsarasab (= 1×) peers Jae-Seong Shim

Countries citing papers authored by Ubonvan Termsarasab

Since Specialization
Citations

This map shows the geographic impact of Ubonvan Termsarasab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ubonvan Termsarasab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ubonvan Termsarasab more than expected).

Fields of papers citing papers by Ubonvan Termsarasab

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ubonvan Termsarasab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ubonvan Termsarasab. The network helps show where Ubonvan Termsarasab may publish in the future.

Co-authorship network of co-authors of Ubonvan Termsarasab

This figure shows the co-authorship network connecting the top 25 collaborators of Ubonvan Termsarasab. A scholar is included among the top collaborators of Ubonvan Termsarasab based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ubonvan Termsarasab. Ubonvan Termsarasab is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Lee, Jae‐Young, Ubonvan Termsarasab, Dong‐Hyun Kim, et al.. (2017). Chemosensitizing indomethacin-conjugated chitosan oligosaccharide nanoparticles for tumor-targeted drug delivery. Acta Biomaterialia. 57. 262–273. 61 indexed citations
2.
Lee, Jae‐Young, Ubonvan Termsarasab, Ju-Hwan Park, et al.. (2016). Dual CD44 and folate receptor-targeted nanoparticles for cancer diagnosis and anticancer drug delivery. Journal of Controlled Release. 236. 38–46. 98 indexed citations
3.
Park, Ju-Hwan, Hyun‐Jong Cho, Ubonvan Termsarasab, et al.. (2014). Interconnected hyaluronic acid derivative-based nanoparticles for anticancer drug delivery. Colloids and Surfaces B Biointerfaces. 121. 380–387. 21 indexed citations
4.
Kim, Dae‐Duk, Ubonvan Termsarasab, Hyun‐Jong Cho, et al.. (2014). Preparation and characterization of self-assembled nanoparticles based on low-molecular-weight heparin and stearylamine conjugates for controlled delivery of docetaxel. International Journal of Nanomedicine. 9. 5711–5711. 22 indexed citations
5.
Termsarasab, Ubonvan, In‐Soo Yoon, Ju-Hwan Park, et al.. (2014). Polyethylene glycol-modified arachidyl chitosan-based nanoparticles for prolonged blood circulation of doxorubicin. International Journal of Pharmaceutics. 464(1-2). 127–134. 43 indexed citations
6.
Park, Ju-Hwan, Jae‐Young Lee, Ubonvan Termsarasab, et al.. (2014). Development of poly(lactic-co-glycolic) acid nanoparticles-embedded hyaluronic acid–ceramide-based nanostructure for tumor-targeted drug delivery. International Journal of Pharmaceutics. 473(1-2). 426–433. 35 indexed citations
7.
Termsarasab, Ubonvan, Hyun‐Jong Cho, Hyun Tae Moon, et al.. (2013). Self-assembled magnetic resonance imaging nanoprobes based on arachidyl chitosan for cancer diagnosis. Colloids and Surfaces B Biointerfaces. 109. 280–286. 19 indexed citations
8.
Termsarasab, Ubonvan, Hyun‐Jong Cho, Dong Hwan Kim, et al.. (2012). Chitosan oligosaccharide–arachidic acid-based nanoparticles for anti-cancer drug delivery. International Journal of Pharmaceutics. 441(1-2). 373–380. 99 indexed citations
9.
Termsarasab, Ubonvan, Seung-Hak Ko, Jae-Seong Shim, et al.. (2012). Hyaluronic Acid Derivative-Based Self-Assembled Nanoparticles for the Treatment of Melanoma. Pharmaceutical Research. 29(12). 3443–3454. 68 indexed citations
10.
Cho, Hyun‐Jong, Ubonvan Termsarasab, In‐Soo Yoon, et al.. (2011). Development of udenafil-loaded microemulsions for intranasal delivery: In vitro and in vivo evaluations. International Journal of Pharmaceutics. 423(2). 153–160. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026